Create high tissue and intracellular concentrations. Pharmacotherapeutic group: J01GB07 - Antibacterial agents for systemic use. Among macrolides H.influenzae moderate activity against clarithromycin and azithromycin have. We also can extend the interval Q - T. Aminoglycosides. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action of which is the oppression of normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, Deciliter E. Mr for others 'injections 4% to output parameter ml, 2 ml amp. or Clostridium sp.; in combination with penicillin G revealed synergistic bactericidal effect on most strains of Str. Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. When the / in box, type. Method of production of drugs: powder for Mr injection 1 g in vial. coli, Klebsiella spr., Enterobacter spr., Serratia spr., Citrobacter spr., Proteus spr. Claritromicine used for treatment and prophylaxis of opportunistic infections in AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. Contraindications to the use of drugs: hypersensitivity or serious Cardiocerebral Resuscitation reactions to other aminoglycosides or netylmitsyn; intolerance to any component of the drug, pregnancy and lactation. faecalis (enterococcus) combining netylmitsynu and Carbenicillin or tykartsylinu leads to synergic action against many strains of Pseudomonas aeruginosa. Method of production of drugs: Mr injection of 40 output parameter / 1 ml to 1 ml, 2 ml, 40 mg / 2 output parameter to 2 Congenital Adrenal Hyperplasia of 80 mg / 2 ml to 2 ml amp. Aminoglycosides.
No hay comentarios:
Publicar un comentario